Controlled release of ofloxacin from chitosan-montmorillonite hydrogel

Applied Clay Science

Volumn 50, Issue 1, 2010, Pages 112-117

  Hua, Shuibo ^a,b   Yang, Huixia ^a,b   Wang, Wenbo ^a,b   Wang, Aiqin ^a  

^a LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Chitosan; Drug release; Montmorillonite; Nanocomposite; Ofloxacin

Indexed keywords

CONTROLLED RELEASE; DRUG CARRIER; DRUG ENTRAPMENT; DRUG LOADING; DRUG RELEASE; ELECTROSTATIC INTERACTIONS; INTERCALATED NANOCOMPOSITES; IONIC CROSSLINKING; MONTMORILLONITE; OFLOXACIN; SODIUM TRIPOLYPHOSPHATE; SUSTAINED RELEASE; SWELLING BEHAVIOR;

CHITIN; CHITOSAN; CLAY MINERALS; DRUG INTERACTIONS; DRUG PRODUCTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; NANOCOMPOSITES; SILICATE MINERALS; SODIUM; X RAY DIFFRACTION;

HYDROGELS;

ANTIBIOTICS; COMPOSITE; FTIR SPECTROSCOPY; MONTMORILLONITE; NANOTECHNOLOGY; POLYSACCHARIDE;

EID: 77957019450     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2010.07.012     Document Type: Article

References (27)

1. Agnihotri S.A., Mallikarjuna N.N., Aminabhavi T.M. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 2004, 100:5-28.
2. Aguzzi C., Cerezo P., Viseras C., Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007, 36:22-36.
3. Byrne R.S., Deasy P.B. Use of porous aluminosilicate pellets for drug delivery. J. Microencapsul. 2005, 22:423-437.
4. Cui Y., Zhang Y., Tang X. In vitro and in vivo evaluation of ofloxacin sustained release pellets. Int. J. Pharm. 2008, 360:47-52.
5. Dang J.M., Leong K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 2006, 58:487-499.
6. Depan D., Kumar A.P., Singh R.P. Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater. 2009, 5:93-100.
7. Ding X., Alani A.W.G., Robinson J.R. Extended-release and targeted drug delivery systems. Remington: the Science and Practice of Pharmacy 2002, 939-964. Lippincott Williams & Wilkins, USA, Chap. 47. 21st Edition. D.B. Troy (Ed.).
8. Ginebra M.P., Traykova T., Planell J.A. Calcium phosphate cements as bone drug delivery systems: a review. J. Control. Release 2006, 113:102-110.
9. Günister E., Pestreli D., ünlu C.H., Atici O., Güngör N. Synthesis and characterization of chitosan-MMT biocomposite systems. Carbohydr. Polym. 2007, 67:358-365.
10. Herrera P., Burghardt R.C., Philips T.D. Adsorption of Salmonella enteritidis by cetylpyridinium-exchanged montmorillonite clays. Vet. Microbiol. 2000, 74:259-272.
11. Jung H., Kim H.M., Choy Y.B., Hwang S.J., Choy J.H. Itraconazole-laponite: kinetics and mechanism of drug release. Appl. Clay Sci. 2008, 40:99-107.
12. Li B.X., He J., Evans D.G., Duan X. Inorganic layered double hydroxides as a drug delivery system-intercalation and in vitro release of fenbufen. Appl. Clay Sci. 2004, 27:199-207.
13. Lin J.J., Wei J.C., Juang T.Y., Tsai W.C. Preparation of protein-silicate hybrids from polyamine intercalation of layered montmorillonite. Langmuir 2007, 23:1995-1999.
14. Liu K.H., Liu T.Y., Chen S.Y., Liu D.M. Drug release behavior of chitosan-montmorillonite nanocomposite hydrogels following electrostimulation. Acta Biomater. 2008, 4:1038-1045.
15. Malmsten M. Soft drug delivery systems. Soft Matter 2006, 2:760-769.
16. Nunes C.D., Vaz P.D., Fernandes A.C., Ferreira P., Romão C.C., Calhorda M.J. Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur. J. Pharm. Biopharm. 2007, 66:357-365.
17. Papadimitriou S., Bikiaris D., Avgoustakis K., Karavas E., Georgarakis M. Chitosan nanoparticles loaded with dorzolamide and pramipexole. Carbohydr. Polym. 2008, 73:44-54.
18. Pongjanyakul T., Khunawattanakul W., Puttipipatkhachorn S. Physicochemical characterizations and release studies of nicotine-magnesium aluminum silicate complexes. Appl. Clay Sci. 2009, 44:242-250.
19. Puttipipatkhachorn S., Pongjanyakul T., Priprem A. Molecular interaction in alginate beads reinforced with sodium starch glycolate or magnesium aluminum silicate, and their physical characteristics. Int. J. Pharm. 2005, 293:51-62.
20. Sezer A.D., Akbuga J. Controlled-release of piroxicam from chitosan beads. Int. J. Pharm. 1995, 121:113-116.
21. Sriamornsak P., Nunthanid J., Luangtana-Anan M., Puttipipatkhachorn S. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid. Eur. J. Pharm. Biopharm. 2007, 67:227-235.
22. Taa H.T., Hana H., Larsonb I., Dassc C.R., Dunstana D.E. Chitosan-dibasic orthophosphate hydrogel: a potential drug delivery system. Int. J. Pharm. 2009, 371:134-141.
23. Takahashi T., Yamada Y., Kataoka K., Nagasaki Y. Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles. J. Control. Release 2005, 107:408-416.
24. Thanou M., Florea B.I., Langemeyer M.W.E., Verhoef J.C., Junginger H.E. N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm. Res. 2000, 17:27-31.
25. Tomonori N., Hiroshi K. Development of effective protein delivery system to mucosa-associated lymphoid tissues (MALT) with M cell-targeting technology. Drug Deliv. Syst. 2008, 23:529-533.
26. Wang X.Y., Du Y.M., Luo J.W. Biopolymer/montmorillonite nanocomposite: preparation, drug-controlled release property and cytotoxicity. Nanotechnology 2008, 19:1-7.
27. Zheng J.P., Luan L., Wang H.Y., Xi L.F., Yao K.D. Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl. Clay Sci. 2007, 36:297-301.